Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells 376 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $375.39, for a total value of $141,146.64. Following the completion of the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,067,272.73. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Robert Desantis also recently made the following trade(s):

• On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The stock was sold at an average price of $369.92, for a total value of $554,140.16.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.16, for a total value of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.80, for a total value of $7,992,564.80.

Intuitive Surgical Trading Down 0.9 %

Intuitive Surgical stock traded down $3.52 during mid-day trading on Tuesday, hitting $370.62. The company’s stock had a trading volume of 1,204,415 shares, compared to its average volume of 1,637,873. The firm has a market capitalization of $131.46 billion, a PE ratio of 67.53, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock’s fifty day moving average is $386.10 and its two-hundred day moving average is $347.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.00 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC increased its position in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares in the last quarter. Able Wealth Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Atticus Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 85.4% during the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 41 shares during the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on ISRG. Truist Financial boosted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Robert W. Baird dropped their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. Citigroup lifted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. BTIG Research lifted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Finally, Barclays lifted their target price on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.